Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Panobinostat Biological Correlates Study

NCT01658241

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Completed

NMP in Relapsed / Refractory Myeloma

NCT02468687

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

View Trial Details

Completed

Association Between Cancer and Sarcoidosis

NCT03844698

Conditions: Cancer, Hemic and Lymphatic Diseases, Hypersensitivity, +6 more
Locations: University of Miami, Miller School of Medicine Miami, Florida, United States

View Trial Details

Completed

Alemtuzumab (Campath) to Treat T-Large Granular Lymphocyte Leukemia

NCT00345345

Conditions: Agranulocytosis, Cytopenia, Hematologic Diseases, +15 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

NCT00061945

Conditions: Acute Undifferentiated Leukemia, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, +23 more
Locations: Cancer and Leukemia Group B Chicago, Illinois, United States

View Trial Details

Completed

Feasibility and Accuracy of Nanosensor-based Cancer Diagnosis at the Point-of-care (Chedza)

NCT04119154

Conditions: Breast Diseases, Breast Neoplasms, Hemic and Lymphatic Diseases, +10 more
Locations: Botswana Harvard AIDS Institute Gaborone, Botswana

View Trial Details

Completed

Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL)

NCT02689453

Conditions: Adult T-Cell Leukemia (ATL), Cutaneous T Cell Lymphoma (CTCL), Hematologic Diseases, +21 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study of GC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL

NCT03825718

Conditions: B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
Locations: Hebei Yanda Ludaopei Hospital Sanhe, Hebei, China

View Trial Details

Completed

Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases

NCT00450450

Conditions: Bone Marrow Diseases, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, +29 more
Locations: Children's Oncology Group Arcadia, California, United States

University of California San Francisco Medical Center-Parnassus San Francisco, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Childrens Memorial Hospital Chicago, Illinois, United States

View all 21 locations

View Trial Details

Completed

Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma

NCT01026220

Conditions: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +9 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Birmingham, Alabama, United States

University of South Alabama Mobile, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

View all 177 locations

View Trial Details